These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [The role of anti-leukotriene drugs in the management of chronic asthma]. Adachi M; Imai T; Minoguchi K Arerugi; 1999 Jul; 48(7):683-5. PubMed ID: 10481351 [No Abstract] [Full Text] [Related]
26. [Leukotriene modifiers: the role in the treatment of childhood asthma]. Tal A Harefuah; 1999 Jun; 136(11):889-92. PubMed ID: 10955139 [No Abstract] [Full Text] [Related]
27. Leukotriene antagonists and symptom control in chronic persistent asthma. Green RH; Pavord ID Lancet; 2001 Jun; 357(9273):1991-2. PubMed ID: 11438126 [No Abstract] [Full Text] [Related]
28. Which patients with asthma could benefit from using anti-leukotriene drugs: an evidence based review. Joos GF Pol Arch Med Wewn; 2008 Dec; 118(12):689-90. PubMed ID: 19202944 [No Abstract] [Full Text] [Related]
29. Leukotriene receptor antagonists. Altinger JA Lippincotts Prim Care Pract; 1998; 2(6):634-42. PubMed ID: 9883158 [No Abstract] [Full Text] [Related]
30. Leukotriene receptor antagonist treatment of asthma: are we there yet? Kercsmar CM J Pediatr; 1999 Mar; 134(3):256-9. PubMed ID: 10064656 [No Abstract] [Full Text] [Related]
31. [Antileukotriene drugs in the treatment of obstructive lung diseases and rhinitis]. Mastalerz L; Kania A Pneumonol Alergol Pol; 2010; 78(1):74-8. PubMed ID: 20162522 [TBL] [Abstract][Full Text] [Related]
32. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma. Devillier P; Baccard N; Advenier C Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986 [TBL] [Abstract][Full Text] [Related]
33. [Antileukotrienes in the therapy of bronchial asthma]. Rossi G Recenti Prog Med; 1998 Dec; 89(12):654-6. PubMed ID: 9951316 [No Abstract] [Full Text] [Related]
34. [Bronchial asthma--is it necessary to change treatment philosophy?]. Grzanka A; Rogala B Pol Arch Med Wewn; 2002 Mar; 107(3):283-9. PubMed ID: 12107989 [No Abstract] [Full Text] [Related]
35. [The therapeutic potentials of antileukotriene preparations in bronchial asthma patients]. Fedoseev GB; Emel'ianov AV; Krasnoshchekova OI Ter Arkh; 1998; 70(8):81-4. PubMed ID: 9770758 [No Abstract] [Full Text] [Related]
36. Asthma: resource use and costs for inhaled corticosteroid vs leukotriene modifier treatment--a meta-analysis. Halpern MT; Khan ZM; Stanford RH; Spayde KM; Golubiewski M J Fam Pract; 2003 May; 52(5):382-9. PubMed ID: 12737772 [TBL] [Abstract][Full Text] [Related]
38. Introduction: the anti-inflammatory role of cysteinyl leukotriene receptor antagonists in asthma. Holgate ST; Peters-Golden M J Allergy Clin Immunol; 2003 Jan; 111(1 Suppl):S1-4. PubMed ID: 12532082 [No Abstract] [Full Text] [Related]
39. Introduction: leukotriene receptor antagonists--exciting new approach to the management of childhood asthma. Warner JO Allergy; 2001; 56 Suppl 66():5-6. PubMed ID: 11421934 [No Abstract] [Full Text] [Related]
40. [Leukotriene antagonists against bronchial asthma. Not a replacement for steroids]. MMW Fortschr Med; 1999 Sep; 141(38):56. PubMed ID: 10904622 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]